Background To develop an effective vaccine against a novel viral pathogen, it is important
to understand the longitudinal antibody responses against its first infection. Here we …

Some patients who recover from coronavirus disease 2019 (COVID-19) have prolonged
symptoms such as dyspnea, fatigue, cough, and dysosmia for longer than 120 days after …

The spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
plays a key role in viral infectivity. It is also the major antigen stimulating the host's protective …

Background The empirical basis for a quantitative assessment of the disease burden imposed
by long-COVID is currently scant. We aimed to inform the disease burden caused by long-…

Introduction Information on the effectiveness of personal protective equipment (PPE) for
preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among …

In early 2020, Japan repatriated 566 nationals from China. Universal laboratory testing and
14-day monitoring of returnees detected 12 cases of severe acute respiratory syndrome …

Objective To evaluate the efficacy and safety of direct hemoperfusion using a polymyxin B‐immobilized
polystyrene column (PMX‐DHP) in severe acute respiratory syndrome …

HLA‐A, ‐C, ‐B, and ‐DRB1 genotypes were analyzed in 178 Japanese COVID‐19 patients
to investigate the association of HLA with severe COVID‐19. Analysis of 32 common HLA …

Introduction Among patients with coronavirus disease 2019 (COVID-19), the factors that affect
anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody production …

Interventions: Not applicable. Measurements and Main Results: This is single-center study,
national center hospital designated for infectious disease. Fifty-eight patients who tested …